Investor Alert

London Markets Open in:

Company Close Updates Archives | Email alerts

Jan. 27, 2021, 5:06 p.m. EST

BioNTech SE ADR outperforms market despite losses on the day

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

The BioNTech SE ADR BNTX shed 0.30% to $105.97 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.57% to 3,750.77 and Dow Jones Industrial Average DJIA falling 2.05% to 30,303.17. This was the ADR's second consecutive day of losses. BioNTech SE ADR closed $25.03 short of its 52-week high ($131.00), which the company reached on December 11th.

Despite its losses, the ADR outperformed some of its competitors Wednesday, as AbbVie Inc. ABBV fell 5.52% to $102.79 and Amgen Inc. AMGN fell 2.92% to $251.06. Trading volume (2.1 M) remained 2.0 million below its 50-day average volume of 4.1 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.